Dr. Alexander Meier has in depth pharmaceutical law expertise with more than 16 years of experience as both outside counsel and inhouse lawyer and is specialised in European and German regulatory matters concerning pharmaceuticals, biologicals and medical devices.
For the last eleven years Alex has worked for Novartis. Within Novartis Alex held several roles of increasing responsibility, such as Head of Legal Germany for Sandoz and as Global Head, Legal of TechOps, Regulatory and Development for Novartis Pharma. Most recently Alex assumed the role of Head of Legal, Global and Pharma Drug Development of Novartis, providing in particular EU regulatory legal support to all Global Development Functions and across the portfolio of the originator divisions (general medicines and oncology including cell & gene products).
Before that, he has worked for more than 5 years in 2 pharmaceutical law firm boutiques in Munich, advising both innovator and generic businesses.
Alex studied law at the University of Augsburg (Germany) and the University of Lausanne (Switzerland). He is a German trained lawyer and holds a Ph.D. in Genetic Engineering and Food Law. Alex is also lecturer at the University of Marburg (Germany) at the master degree program (LL.M.) for pharma law. Alex regularly publishes scientific articles as well as speaks at international congresses, and is co-author and co-publisher of the textbook “Pharmarecht” (2014).